Dietary furazolidone (500 ppm or higher) significantly slowed the growth of chicks fed either a conventional or a purified diet and of turkeys fed a conventional diet. Deaths were significantly increased in turkeys fed 500 ppm and in chicks fed 700 ppm in the purified diet. Ratio of heart to body weight was significantly increased by furazolidone in turkeys, but not in chicks. Furazolidone did not induce anemia in either species. Turkeys and chicks differed markedly in cardiac response to toxic levels of furazolidone.
INTRODUCTION
Cardiac hypertrophy can be produced in animals by induced hypertension, anemia, maintaining animals at high altitude, thyroid hormones, prolonged strenuous exercise, or other means (1). In a "round heart" syndrome in commercial turkey flocks the hearts have a blunt apex and are enlarged (2) . The etiology of that disease has not been determined. Inclusion of as little as 300 ppm of furazolidone [N (5-nitro-2-furfiurylidene) -3-amino-2-oxazolidone] in the diet caused cardiac enlargement in turkey poults (3,4) and adding silver nitrate (900 ppm silver) to the diet caused a marked enlargement of hearts in turkeys, along with anemia (5). Since supplementing the latter (silver) diet with 50 ppm copper prevented the conditions, cardiac enlargement was apparently the result of anemia caused by a silver-induced copper deficiency. The present studies were conducted to determine whether cardiac enlargement in turkeys produced by furazolidone toxicity was associated with anemia, and whether chicks fed two diets differing in sources of protein and carbohydrate would respond similarly to furazolidone toxicity.
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MATERIALS AND METHODS
The first experiment was conducted with one-day-old SingleComb White Leghorn cockerels maintained in electrically heated battery brooders with wire floors, with feed and water supplied ad libitum. Three groups of ten chicks each were fed each of the experimental diets. Furazolidone at five levels from 0 to 700 ppm was added to both a conventional and a purified diet to determine the effect of diet on response of chicks to the drug. The conventional diet was composed of 60.4% corn, 28.3% soybean meal, 6% meat and bone meal, 1.5% animal fat, 1.5% dehydrated alfalfa, plus vitamin, mineral, and amino acid supplements. The purified diet consisted of 18% casein, 9% gelatin, 58.7% glucose monohydrate, 5% soybean meal, 4% corn oil, and vitamin, mineral, and amino acid supplements. The chicks were fed the diets for four weeks, during which time mortality was recorded, but necropsies were not performed on the dead birds. At the end of the experiment, the chicks were weighed and a blood sample was obtained by cardiac puncture from three chicks from each pen for hematological measurements. Hearts were removed from all birds in each pen to obtain mean heart weight. Packed cell volume on the blood samples was determined by the microhematocrit method of Johnson (6). Erythrocyte counts were obtained by use of a Coulter counter (model F), and the hemoglobin quantity was determined by the acid hematin method (7).
A second experiment was conducted with one-day-old Large White male turkeys. Levels of furazolidone from 0 to 900 ppm were fed to the turkeys receiving a conventional diet for four weeks. The diet consisted of 42% corn, 41% soybean meal, 5 % poultry byproduct meal, 5% fish meal, 2.5% animal fat, 1.5% dehydrated alfalfa meal, plus vitamin, mineral, and amino acid supplements. The poults were managed similarly to the chicks, and the same measurements were made at the conclusion of the experiment.
RESULTS
Added furazolidone of 300 or more ppm significantly depressed body weight below that with 100 ppm furazolidone in chicks fed either the conventional or purified diet (Table 1) . Growth was significantly less for chicks fed the purified diet, but the relation of growth rate to furazolidone level was similar in both. Mortality was significantly increased in chicks fed the plurified basal with the 597 highest level of furazolidone (700 ppm) but not in chicks fed the conventional diet. Mean heart weight was not elevated by furazolidone. The apparent decrease in heart weight of groups receiving furazolidone at more than 100 mg/kg was caused by a decrease in body weights. Ratios of heart weight to body weight were similar among all of the treatments (Fig. 1 ). There were no significant differences in erythrocyte numbers, hemoglobin concentration, or packed cell volume of blood samples between the various treatments, showing that the chicks were not anemic.
In turkeys, body weight was significantly reduced and mortality significantly increased with levels of 500 ppm furazolidone or higher (Table 2) . No anemia was observed. The absolute heart weight was greater in turkey poults fed diets containing furazolidone than in poults fed the diet with no furazolidone. Ratios of heart weight to body weight in chicks fed either the conventional AValues in each column not having a common following letter are significantly different (P or purified diets compared with those of turkeys fed a different conventional ration show that these two avian species differ markedly in response to furazolidone (Fig. 1) .
DISCUSSION
The results presented here confirm those reported by others (3,4) that toxic levels of furazolidone fed to young turkeys results in cardiac enlargement and high mortality. Feeding to chicks levels of furazolidone that were toxic to poults failed to cause cardiac enlargement, even though the higher levels significantly depressed growth rate. The reason for this difference between avian species in response to furazolidone is not known, though it may be related to the slower growth in chicks. Rapidly growing broiler chicks may have responded differently to furazolidone than Leghorn chicks. A significant depression in growth rate, however, was observed in both species, demonstrating that furazolidone was affecting metabolism in both chicks and turkeys. Although the conventional diets fed to chicks and turkeys differed in composition, primarily because of a difference in quantitative requirements for nutrients, it is unlikely that this caused the differential response in cardiomyopathy. Chicks appear to have a greater resistance to the disruption of the control mechanisms for normal heart development caused by furazolidone in turkeys.
The mechanism by which furazolidone induces cardiac enlargement in turkey poults is not revealed by these experiments. Cardiac hypertrophy is commonly observed in animals whose oxygen requirement has been increased by hypoxic conditions or by reduced oxygen carrying capacity of blood, such as occurs in nutritional anemas. No evidence of anemia was seen in poults exhibiting cardiac enlargement. Therefore, the cardiomyopathies are not caused by simple reduction in the oxygen carrying capacity of the blood.
Certain enzymes have been shown to be inhibited by fiurazolidone and changes in metabolism caused by the inefficiency of these enzymes may be related to changes in heart size. In vitro studies have demonstrated that glucose utilization by testes of rats was inhibited by furazolidone (8). The interference appeared to be at the formation of acetyl Co-A (9). Furazolidone also apparently inhibits monoamine oxidase (10), an enzyme found mainly in the mitochondria of several tissues that catalyzes oxidative deamination of various amines. Monoamine oxidase probably exists in multiple forms in different tissues with different substrate specificities since isolated monoamine oxidase forms react differently to inhibitors (11). Monoamine oxidase inhibitors reduce hypertension, and furazolidone exerted a significant hypertensive action in man when administered at levels equivalent to the higher levels used in the present studies (12). Epinephrine and tyramine, compounds oxidized by monoamine oxidase, are vassopressor substances, and inhibition of monoamine oxidase could lead to the accumulation of these compounds in the tissues and, therefore, to hypertension, a known cause of cardiac enlargement in animals. Tyramine apparently does not accumulate to any extent in mammalian tissues. Hypertensive crisis developed in patients on tranylcypromine, a monoamine oxidase inhibitor, shortly after eating chicken livers (13). Such livers were found to contain 94 1Ag tyramine per g whereas fresh livers contained less than 0.5 ,Ag. Thus the tyramine apparently formed in the food livers during storage or cooking. Tyramine may have been present in some of the feedstuffs such as meat and bone meal or poultry by-product meal used in the conventional diets in the present study.
Although the cardiac enlargement observed in turkey poults in which a copper deficiency was induced by dietary silver (5) may be explained on the basis of reduced oxygen-carrying capacity of the blood associated with the development of anemia, it is also possible that the activity of monoamine oxidase could play a role. Since some forms of monoamine oxidase contain copper, their activity should be reduced in a copper deficiency.
